These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 3495914)
21. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Yoshida M; Takeuchi M; Streilein JW Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698 [TBL] [Abstract][Full Text] [Related]
23. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of T cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Wolos JA; Frondorf KA; Davis GF; Jarvi ET; McCarthy JR; Bowlin TL J Immunol; 1993 Apr; 150(8 Pt 1):3264-73. PubMed ID: 8468468 [TBL] [Abstract][Full Text] [Related]
25. Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppression. Chen W; Cheever MA J Immunol; 1994 May; 152(10):4767-74. PubMed ID: 8176202 [TBL] [Abstract][Full Text] [Related]
26. The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro. Malek TR; Ortega G; Jakway JP; Chan C; Shevach EM J Immunol; 1984 Oct; 133(4):1976-82. PubMed ID: 6432904 [TBL] [Abstract][Full Text] [Related]
27. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2. Feuerstein N; Huang D; Hinrichs SH; Orten DJ; Aiyar N; Prystowsky MB J Immunol; 1995 Jan; 154(1):68-79. PubMed ID: 7995960 [TBL] [Abstract][Full Text] [Related]
28. The tumor promoter teleocidin induces IL 2 receptor expression and IL 2-independent proliferation of human peripheral blood T cells. Isakov N; Bleackley RC; Shaw J; Altman A J Immunol; 1985 Oct; 135(4):2343-50. PubMed ID: 3928744 [TBL] [Abstract][Full Text] [Related]
29. Differential sensitivity of human lymphocyte subpopulations to azathioprine. Dimitriu A; Fauci AS Transplant Proc; 1979 Mar; 11(1):878-81. PubMed ID: 313109 [No Abstract] [Full Text] [Related]
30. Attempt at simplification of the rosette -- inhibition test for routine use in patients under immunosuppressive therapy. Nowaczyk M; Laudański Z; Skopińska E Ann Med Sect Pol Acad Sci; 1976; (3):159-67. PubMed ID: 973433 [TBL] [Abstract][Full Text] [Related]
31. Initial characterization of humoral IL-2 response inhibition following donor-specific transfusions under azathioprine immunosuppression. Tyler JD; Anderson CB; Sicard GA Transplantation; 1987 Jun; 43(6):879-87. PubMed ID: 3495914 [TBL] [Abstract][Full Text] [Related]
32. Modulation of the response to interleukin 2 in recipients of donor-specific transfusions under azathioprine immunosuppression. Tyler JD; Anderson CB; Sicard GA Transplantation; 1986 Nov; 42(5):502-6. PubMed ID: 2947355 [TBL] [Abstract][Full Text] [Related]
33. Interleukin 2 response inhibition following donor specific transfusions given with azathioprine. Tyler JD; Anderson CB; Sicard GA Transplant Proc; 1987 Feb; 19(1 Pt 3):2258-61. PubMed ID: 3547923 [No Abstract] [Full Text] [Related]
34. Inhibition of interleukin-2-induced proliferation of mouse T cells by normal mouse serum. Maca RD J Biol Response Mod; 1983; 2(4):360-8. PubMed ID: 6606023 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response. Volk HD; Müller S; Yarkoni S; Diamantstein T; Lorberboum-Galski H J Immunol; 1994 Sep; 153(6):2497-505. PubMed ID: 8077661 [TBL] [Abstract][Full Text] [Related]